BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6193686)

  • 1. Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytes.
    Fry DW; Gewirtz DA; Yalowich JC; Goldman ID
    Adv Exp Med Biol; 1983; 163():215-34. PubMed ID: 6193686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the intracellular levels of polyglutamyl derivatives of methotrexate by vincristine and probenecid in Ehrlich ascites tumor cells.
    Fry DW; Yalowich JC; Goldman ID
    Cancer Res; 1982 Jul; 42(7):2532-6. PubMed ID: 6177396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
    Poser RG; Sirotnak FM
    Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and retention of methotrexate polyglutamates in Ehrlich ascites carcinoma cells.
    Balińska M
    Drugs Exp Clin Res; 1986; 12(6-7):551-4. PubMed ID: 2427298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
    Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
    Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of formation and efflux of methotrexate polyglutamates with cultured hepatic cells.
    Galivan J; Balinska M
    Adv Exp Med Biol; 1983; 163():235-46. PubMed ID: 6193687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of methotrexate polyglutamates in rat hepatocytes.
    Gewirtz DA; White JC; Randolph JK; Goldman ID
    Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, binding and intracellular retention of methotrexate polyglutamates by cultured human breast cancer cells.
    Schilsky RL; Jolivet J; Bailey BD; Chabner BA
    Adv Exp Med Biol; 1983; 163():247-57. PubMed ID: 6193688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
    McGuire JJ; Mini E; Hsieh P; Bertino JR
    Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate polyglutamates in cultured human cells.
    Rosenblatt DS; Whitehead VM
    Adv Exp Med Biol; 1983; 163():275-85. PubMed ID: 6193690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate polyglutamate synthesis by cultured human breast cancer cells.
    Schilsky RL; Bailey BD; Chabner BA
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2919-22. PubMed ID: 6156458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool.
    Balińska M
    Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory aspects of the glutamylation of methotrexate in cultured hepatoma cells.
    Nimec Z; Galivan J
    Arch Biochem Biophys; 1983 Oct; 226(2):671-80. PubMed ID: 6195970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
    Allegra CJ; Boarman D
    Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
    Poser RG; Sirotnak FM; Chello PL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and properties of 7-hydroxymethotrexate polyglutamyl derivatives in Ehrlich ascites tumor cells in vitro.
    Fabre G; Fabre I; Matherly LH; Cano JP; Goldman ID
    J Biol Chem; 1984 Apr; 259(8):5066-72. PubMed ID: 6715337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
    Yalowich JC; Fry DW; Goldman ID
    Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin-dependent suppression in glutamyl hydrolase activity and elevated cellular methotrexate polyglutamates.
    Galivan J; Rhee MS
    Biochem Pharmacol; 1995 Nov; 50(10):1659-63. PubMed ID: 7503769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
    Cowan KH; Jolivet J
    J Biol Chem; 1984 Sep; 259(17):10793-800. PubMed ID: 6206061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.